55 algorithm-development-"Multiple"-"Prof"-"Prof"-"Simons-Foundation"-"St" positions at University of Basel in Switzerland
Sort by
Refine Your Search
-
driving the development of innovative therapies that address unmet medical needs. With over 70 research groups and 800 employees, the Department of Biomedicine is the largest department within
-
, environment, society and health as well as health systems and interventions. The Digital Health Unit is currently looking for a strategic implementer to further develop its thematic profile and portfolio as
-
Ideas, SBB, and gfs.bern, you will collaborate with Dr. Andrea Bublitz to develop and validate LLM-assisted pipelines that reduce data-collection costs while maintaining validity for marketing and opinion
-
Your position • Further develop and ensure the quality of risk assessments (institutional, local offices, projects etc.): Conduct risk assessments, identify areas for improvement, and implement
-
a Swiss-wide research consortium funded by the Swiss National Science Foundation (SNSF). AntiResist is transforming antibiotic discovery and development through in vitro modelling of in-patient
-
research on synthetic data. In an Innosuisse project with Boomerang Ideas, SBB, and gfs.bern, you will collaborate with Dr. Andrea Bublitz to develop and validate LLM-assisted pipelines that reduce data
-
discovery and development through in vitro modelling of in-patient conditions in order to address antibiotic resistance, a problem of global importance. To reach this goal, AntiResist has assembled a panel of
-
The Division of Computational Pharmacy, Department of Pharmaceutical Sciences, is offering a Senior Scientist position to develop and apply cutting-edge computational methodology for drug discovery
-
disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees, the Department of Biomedicine is the largest
-
discovery and development through in vitro modelling of in-patient conditions in order to address antibiotic resistance, a problem of global importance. To reach this goal, AntiResist has assembled a panel of